510(k) · Cleared
ClearedAhead 300
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Brainscope Company, Inc. · PIW Brain Injury Adjunctive Interpretive Electroencephalograph Assessment Aid
Cleared on Sep 22, 2016 as substantially equivalent to K143643 (Brainscope Company, Inc., 2015) and 2 other predicates after a 160-day review. Its family tree reaches back 2 generations to 1980. 6 later devices descend from it.
- Decided
- Sep 22, 2016
- Review
- 160 days
- Class
- Class II
- Product code
- PIW
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 2 generations to K801604 (1980). 18 ancestors in all. 6 later devices descend from it, 1 citing it directly.
- Root · 2 generations backK801604 Pathfinder Electrodiagnostic SystemNicolet Biomedical Instruments · 1980
- 1 generation backK974748 Neurometric Analysis SystemNxlink, Ltd. · 1998
- This deviceK161068 Ahead 300Brainscope Company, Inc. · 2016
- Descendant · cites it directly · 5 of its ownK181179 BrainScope OneBrainscope Company, Inc. · 2018
- Descendant · 2 generations on · 3 of its ownK183241 BrainScope TBI (Model: Ahead 400)Brainscope Company, Inc. · 2019
- Descendant · 3 generations on · 2 of its ownK190815 BrainScope TBIBrainscope Company, Inc. · 2019
- Descendant · 4 generations on · 1 of its ownK231914 Nurochek-II SystemHeadsafe Mfg Pty, Ltd. · 2023
- Descendant · 5 generations on · 0 of its ownK243426 Nurochek-Pro SystemHeadsafe Mfg Pty, Ltd. · 2025
Showing 5 of 6 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 6 · See all- K181179BrainScope OneBrainscope Company, Inc. · 2018 · cites it directly5descendants
- K183241BrainScope TBI (Model: Ahead 400)Brainscope Company, Inc. · 2019 · 2 generations on3descendants
- K190815BrainScope TBIBrainscope Company, Inc. · 2019 · 3 generations on2descendants
- K231914Nurochek-II SystemHeadsafe Mfg Pty, Ltd. · 2023 · 4 generations on1descendant
- K243426Nurochek-Pro SystemHeadsafe Mfg Pty, Ltd. · 2025 · 5 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K801604 | Pathfinder Electrodiagnostic System | Nicolet Biomedical Instruments | 1980 | — |
| −1 | K974748 | Neurometric Analysis System | Nxlink, Ltd. | 1998 | — |
| 0 (this device) | K161068 | Ahead 300 | Brainscope Company, Inc. | 2016 | — |
| +1 | K181179 | BrainScope One | Brainscope Company, Inc. | 2018 | — |
| +2 | K183241 | BrainScope TBI (Model: Ahead 400) | Brainscope Company, Inc. | 2019 | — |
| +3 | K190815 | BrainScope TBI | Brainscope Company, Inc. | 2019 | — |
| +4 | K231914 | Nurochek-II System | Headsafe Mfg Pty, Ltd. | 2023 | — |
| +5 | K243426 | Nurochek-Pro System | Headsafe Mfg Pty, Ltd. | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1989 | 1 | 0 |
| 1991 | 3 | 0 |
| 1995 | 2 | 0 |
| 2014 | 1 | 0 |
| 2015 | 3 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2018 | 2 | 0 |
| 2019 | 2 | 0 |
| 2023 | 1 | 0 |
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in PIW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new PIW device
- #1 K231914 Nurochek-II Systemscore 11.1 · 6 generations · no Class I recall
- #2 Held for the reportin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K143643 | Brainscope Ahead 200Summary page 4…Neurology Product Codes: PIW, PKQ, OLU Predicate Devices: BrainScope Ahead 200 (K143643) ANAM Test System: Military Battery (K150154)… | 2015 |
| * | K150154 | ANAM Test System: Military BatterySummary page 4…KQ, OLU Predicate Devices: BrainScope Ahead 200 (K143643) ANAM Test System: Military Battery (K150154) Neurometric Analysis System (K974748) 1 Prepared in accordan… | 2015 |
| * | K974748 | Neurometric Analysis SystemSummary page 4…) ANAM Test System: Military Battery (K150154) Neurometric Analysis System (K974748) 1 Prepared in accordance with 21 CFR § 807.87(h) and 21 CFR § 807.92(c).… | 1998 |
What descends from it? (6)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K181179 | BrainScope One | 2018 | 5 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 36 years and passes through 3 companies; a new generation was cleared every 18.2 years on median.
- None of the 18 ancestors has a recall.
- Of its descendants, K181179 (Brainscope Company, Inc., 2018) has gone furthest, with 5 descendants of its own.
How does its category compare?
All PIW devicesPIW Brain Injury Adjunctive Interpretive Electroencephalograph Assessment Aid: FDA decisions, review times, recalls and adverse event reports over 20 years. 2016, this device’s year, is highlighted.
FDA decisions per year · PIW
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · PIW
Too few PIW 510(k)s in any year since 2007 to give a median.
Recalls per year · PIW
No recall names PIW since 2007.
Adverse event reports per year · PIW
No MAUDE report names PIW since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 1 | — | 0 | 0 |
| 2015 | 1 | — | 0 | 0 |
| 2016 | 1 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 2 | — | 0 | 0 |
| 2019 | 2 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 1 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 1 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Ahead 300 is indicated for use as an adjunct to standard clinical practice to aid in the evaluation of patients who are being considered for a head CT, who sustained a closed head injury within 72 hours, present with a Glasgow Coma Scale score (GCS) of 13-15, and are between the ages of 18-85 years. The Ahead 300 should not be used as a substitute for a CT scan. The Ahead 300 device is intended to record, measure, analyze, and display brain…
Read the full statement (357 words)
The Ahead 300 is indicated for use as an adjunct to standard clinical practice to aid in the evaluation of patients who are being considered for a head CT, who sustained a closed head injury within 72 hours, present with a Glasgow Coma Scale score (GCS) of 13-15, and are between the ages of 18-85 years. The Ahead 300 should not be used as a substitute for a CT scan.
The Ahead 300 device is intended to record, measure, analyze, and display brain electrical activity utilizing the calculation of standard quantitative EEG (QEEG) parameters from frontal locations on a patient’s forehead. The Ahead 300 calculates and displays raw measures for the following standard QEEG measures: Absolute and Relative Power, Asymmetry, Coherence and Fractal Dimension. These raw measures are intended to be used for post hoc analysis of EEG signals for interpretation by a qualified user.
A negative Ahead 300 Structural Injury Classification using brain electrical activity in patients who sustained a closed head injury within 72 hours, likely corresponds to those with no structural brain injury visible on head CT.
A positive Ahead 300 Structural Injury Classification using brain electrical activity in patients who sustained a closed head injury within 72 hours, likely corresponds to those with a structural brain injury visible on head CT.
An equivocal Ahead 300 Structural Injury Classification using brain electrical activity in patients who sustained a closed head injury within 72 hours, may correspond to structural brain injury visible on head CT or may indicate the need for further observation or evaluation.
The Ahead 300 provides a measure of brain function (EEG Brain Function Index, (BFI)) for the statistical evaluation of the human electroencephalogram(EEG).
The Ahead 300 also provides clinicians with quantitative measures of cognitive performance to aid in the assessment of an individual’s level of cognitive function. These measures do not interact with any other device measures, and are stand alone.
The Ahead 300 also stores and displays electronic versions of standardized clinical assessment tools that should be used in accordance with the assessment tools’ general instructions. These tools do not interact with any other device measures, and are stand alone.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K161068 · printed Nov 6, 2026
Cite this page
510(k) Report. “K161068: Ahead 300.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K161068
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026